SHTYLLA BRUNILDA (Chief Business Officer) sold 15.43K shares of SUTRO BIOPHARMA, INC. on the open market
Open‑market sale worth $72.6K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/29/2023ACC: 0001209191-23-047608
Officer· Chief Business Officer
Since Mar 2023
-15.43K
Net shares
Net seller
$72.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15.43K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15.43K
Price / share
$4.71
Trade value
$72.59K
% of position
New position
8/28/2023
15.43K→0.00
Total
Net shares
−15.43K
Net value
-$72.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/28/2023 | S · Sale | −15.43K | $4.71 | $72.59K | New position | 15.43K | 0.00 |
| Total | −15.43K | -$72.59K | ||||||
Derivative Transactions0
No derivative transactions reported